Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-22-008344

Director sold 6,000 shares at an average $67.83 ($406,970)

  • Director acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
CARTER BRUCE L A Director 2022-03-21 Option exercise +6,000 $25.58 $153,480 6,000 D: show line 1 in the form
CARTER BRUCE L A Director 2022-03-21 Sale −2,676 $66.70 $178,489 3,324 D: show line 2 in the form
CARTER BRUCE L A Director 2022-03-21 Sale −307 $67.23 $20,640 3,017 D: show line 3 in the form
CARTER BRUCE L A Director 2022-03-21 Sale −2,210 $68.66 $151,739 807 D: show line 4 in the form
CARTER BRUCE L A Director 2022-03-21 Sale −807 $69.52 $56,103 0 D: show line 5 in the form
Open-market sales · 6,000 sh · avg $67.83 · $406,970

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
CARTER BRUCE L A Director 2022-03-21 Option exercise · Stock Option (Right to Buy) −6,000 0 D: show line 6 in the form
Loading xslF345X03/form4.xml…